DiaMedica Therapeutics (DMAC) Revenue (2018)
DiaMedica Therapeutics' Revenue history spans 1 years, with the latest figure at $500000.0 for Q3 2018.
- For Q3 2018, Revenue changed N/A year-over-year to $500000.0; the TTM value through Jun 2019 reached $500000.0, changed N/A, while the annual FY2025 figure was -$10000.0, 70.59% up from the prior year.
- Revenue reached $500000.0 in Q3 2018 per DMAC's latest filing.
- In the past five years, Revenue ranged from a high of $500000.0 in Q3 2018 to a low of $500000.0 in Q3 2018.